Last reviewed · How we verify

TPOXX — Competitive Intelligence Brief

TPOXX (TPOXX) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Orthopoxvirus protein synthesis inhibitor. Area: Infectious Disease / Virology.

marketed Orthopoxvirus protein synthesis inhibitor Orthopoxvirus p37 protein Infectious Disease / Virology Small molecule Live · refreshed every 30 min

Target snapshot

TPOXX (TPOXX) — SIGA Technologies. TPOXX inhibits orthopoxvirus protein synthesis by blocking viral RNA polymerase, preventing viral replication.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
TPOXX TARGET TPOXX SIGA Technologies marketed Orthopoxvirus protein synthesis inhibitor Orthopoxvirus p37 protein

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Orthopoxvirus protein synthesis inhibitor class)

  1. SIGA Technologies · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). TPOXX — Competitive Intelligence Brief. https://druglandscape.com/ci/tpoxx. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: